Stock Elyse

Chief Medical Officer at Biohaven Pharmaceutical Holding Co Ltd.

Sold, on record
$6.3M
Dollars the filings state
Form 4 sales
4
Latest Dec 15, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. Oct 15 2019

    Sold 800 shares at $45.01 ($36k)

    Stock Elyse, Chief Medical Officer

    Sold 100% of holdings ($36k position)0 shares leftFirst sale on recordFiling

  2. Oct 18 +3 days

    Sold 17,700 shares at $45.07 ($798k)

    Stock Elyse, Chief Medical Officer

    Sold 100% of holdings ($798k position)0 shares leftFiling

  3. Jun 12 +238 days

    Sold 36,966 shares at $64.83 ($2.4M)

    Stock Elyse, Chief Medical Officer

    Sold 95.2% of holdings ($2.5M position)1,844 shares leftFiling

  4. Dec 15 +551 days

    Sold 28,858 shares at $105.37 ($3M)

    Stock Elyse, Chief Medical Officer

    Sold 79.4% of holdings ($3.8M position)7,467 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (4)

Form 144 notices and Form 4 sales by Stock Elyse
Source
Dec 15, 2021Biohaven Pharmaceutical Holding Co Ltd.Chief Medical OfficerForm 4 sale28,858$3M79.4%UnusualSEC
Jun 12, 2020Biohaven Pharmaceutical Holding Co Ltd.Chief Medical OfficerForm 4 sale36,966$2.4M95.2%UnusualSEC
Oct 18, 2019Biohaven Pharmaceutical Holding Co Ltd.Chief Medical OfficerForm 4 sale17,700$798k100.0%UnusualSEC
Oct 15, 2019Biohaven Pharmaceutical Holding Co Ltd.Chief Medical OfficerForm 4 sale800$36k100.0%UnusualSEC